Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Gas6 Promotes Oligodendrogenesis and Myelination in the Adult Central Nervous System and After Lysolecithin-Induced Demyelination.
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.
Lithium to the Rescue.
Thrombin and Protein C Pathway in Peripheral Nerve Schwann Cells.
How long does it take to diagnose patients with neuromyelitis optica (NMO) using the 2006 diagnostic criteria?
Adipose-Derived Cells (Stromal Vascular Fraction) Transplanted for Orthopedical or Neurological Purposes: Are They Safe Enough?
Validation of a multiplexing technique to determine the intrathecal, polyspecific antiviral immune response in multiple sclerosis.
Proteomics and transcriptomics of peripheral nerve tissue and cells unravel new aspects of the human schwann cell repair phenotype.
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
Evaluation of pulsing magnetic field effects on paresthesia in multiple sclerosis patients, a randomized, double-blind, parallel-group clinical trial.
Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF.
Adherence and persistence to drug therapies for multiple sclerosis: A population-based study.
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.
Sunlight exposure: Do health benefits outweigh harm?
Activated CD4+ and CD8+ T Cell Proportions in Multiple Sclerosis Patients.
Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.
Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
The role of appraisal and coping style in relation with societal participation in fatigued patients with multiple sclerosis: a cross-sectional multiple mediator analysis.
Quantitative MRI in hypomyelinating disorders: Correlation with motor handicap.
Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study.
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
Psychometric properties of a core set of measures of balance for people with cerebellar ataxia secondary to multiple sclerosis.
>CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal.
Acute ganglion cell loss during rapid visual recovery in optic neuritis.
Pages
« first
‹ previous
…
803
804
805
806
807
808
809
810
811
…
next ›
last »